Dx Deals: New Premerger Regulations Could Slow Down Pace of Transactions
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
From - Laboratory Industry Report
During a slow month for diagnostic M&A activity, a noteworthy deal was the closing of Grifols's acquisition of Hologic's blood screening business. The acquired assets include…
From - Laboratory Industry Report
Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew…
From - Laboratory Industry Report
Late last week, LabCorp and the owners of Pathology Associates Medical Laboratories (known as PAML) announced that LabCorp would acquire ownership of…
From - Laboratory Industry Report
In a month with an unusually heavy volume of diagnostic deal making, the headline story was Abbott Laboratories' $25 billion purchase of…
From - Laboratory Industry Report
Although volume of diagnostics industry mergers and acquisitions was up slightly in 2016, the big story of the year were the deals that…
From - Laboratory Industry Report
Abbott officially wants out of its $5.8 billion merger with Alere. Last week, the Illinois-based diagnostics giant asked a Delaware Chancery Court to…